PredictImmune exhibiting at the 14th Congress of ECCO in Copenhagen, Denmark this March
Cambridge, UK, 21st February 2019: Learn about the new and potential game-changing IBD prognostic tool, PredictSURE® IBD at ECCO ‘19 this March in Copenhagen. You’ll get a chance to meet one of the founders of the technology, Dr Paul Lyons, and discuss with him the latest validation data for the prognostic biomarker test in both Crohn’s disease and ulcerative colitis. You can also chat about the availability of the test in the EU with Product Manager, Matthew Fagg.
The PredictImmune team will be at booth #20 of the ECCO ‘19 Congress, Copenhagen, March 6th – 9th 2019
European Crohn’s and Colitis Organisation Conference 2019 (ECCO) | March 6-9th 2019 | Bella Centre, Center Boulevard 5, DK-2300 Copenhagen | Booth 20
‘The main theme of the congress will be “research drives clinical care” as we are witnessing major breakthroughs of innovation due to new drugs hitting the clinic for our patients and many new personalized approaches for individual patient treatments.’ says ECCO President, Silvio Danese.
If you’d like to contact Matthew Fagg before the show to arrange a meeting, please connect via LinkedIn here: https://www.linkedin.com/in/matthew-fagg-43a963b0/ or email: mfagg@predictimmune.com
PredictImmune will also attend the British Society of Gastroenterologists Annual Meeting 2019, 17th – 20th June, Glasgow, UK
We hope to meet you there!
Dr Paul Lyons
Founder & VP Platform Development
Matthew Fagg
Product Manager
Paul Lyons – VP Platform Delivery
Eoin McKinney – CSO
Andy Sandham, Chairman
